Pericardial synovial sarcoma: 14-Year survival with multimodality therapy

Gerry Van Der Mieren, Stefan Willems, Raf Sciot, Herlinde Dumez, Allan Van Oosterom, Willem Flameng, Paul Herijgers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)

Abstract

We report a case of recurrent primary synovial sarcoma of the pericardium. Reverse transcriptase-polymerase chain reaction analysis for t(X,18) demonstrated the presence of the chimeric transcript SYT/SSX. Because of the rarity of this entity, optimal therapy is unknown. The prognosis of this tumor is very poor in previous reports. In this report, we present a case with five recurrences treated by a combination of surgery, chemotherapy, and radiotherapy. The patient survives now for more than 14 years, the longest reported survival of a primary synovial sarcoma of the pericardium.

Original languageEnglish
JournalAnnals of Thoracic Surgery
Volume78
Issue number3
DOIs
Publication statusPublished - 1 Sept 2004

Keywords

  • 32

Fingerprint

Dive into the research topics of 'Pericardial synovial sarcoma: 14-Year survival with multimodality therapy'. Together they form a unique fingerprint.

Cite this